Inflammatory bowel disease pathogenesis: What is new?

Current Opinion in Gastroenterology

Volumn 28, Issue 4, 2012, Pages 301-309

  Scharl, Michael ^a   Rogler, Gerhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

environmental factors; genetic risk factors; inflammatory bowel disease; innate immunity; microbiome; pathogenesis

Indexed keywords

BETA DEFENSIN 1; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CRYOPYRIN; DEXTRAN SULFATE; FUCOSYLTRANSFERASE; GAMMA INTERFERON; INITIATION FACTOR 2ALPHA; INTERFERON REGULATORY FACTOR 5; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 27; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; JANUS KINASE 2; MURAMYL DIPEPTIDE; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 2; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SMAD3 PROTEIN; STAT3 PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; X BOX BINDING PROTEIN 1;

ADAPTIVE IMMUNITY; AUTOPHAGY; CELL DIFFERENTIATION; CELL POPULATION; CROHN DISEASE; DEFENSE MECHANISM; DIET; DISEASE PREDISPOSITION; DNA POLYMORPHISM; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENVIRONMENTAL FACTOR; EPIGENETICS; GENE INTERACTION; GENE LOCUS; GENE PRODUCT; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HEREDITY; HERITABILITY; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE MUCOSA; LIFESTYLE; META ANALYSIS (TOPIC); METABOLISM; MUCOSAL IMMUNITY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; POINT MUTATION; PROTEIN EXPRESSION; REVIEW; SACCHAROMYCES CEREVISIAE; SECRETORY CELL; SOCIAL STATUS; T LYMPHOCYTE; ULCERATIVE COLITIS; UNFOLDED PROTEIN RESPONSE;

ENDOPLASMIC RETICULUM STRESS; GENE-ENVIRONMENT INTERACTION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTESTINES; METAGENOME; RISK FACTORS;

EID: 84862278489     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e328353e61e     Document Type: Review

References (54)

1. Nunes T, Fiorino G, Danese S, Sans M. Familial aggregation in inflammatory bowel disease: Is it genes or environment? World J Gastroenterol 2011; 17:2715-2722.
2. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-Analysis increases to 71 the number of confirmed crohn's disease susceptibility loci. Nat Genet 2010; 42:1118-1125.
3. Anderson CA, Boucher G, Lees CW, et al. Meta-Analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43:246-252.
4. Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology 2011; 140:1704-1712.
5. Khor B, Gardet A, Xavier RJ. Genetics and pathogenesis of inflammatory bowel disease. Nature 2011; 474:307-317.
6. Virgin HW, Todd JA. Metagenomics and personalized medicine. Cell 2011; 147:44-56.
7. Ng SC, Tsoi KK, Kamm MA, et al. Genetics of inflammatory bowel disease in Asia: Systematic review and meta-Analysis. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.21845. [Epub ahead of print]
8. Zuk O, Hechter E, Sunyaev SR, Lander ES. The mystery of missing heritability: Genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012.
9. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011; 43:1066-1073.
10. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol 2010; 11:55-62.
11. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med 2010; 16:90-97.
12. Homer CR, Richmond AL, Rebert NA, et al. ATG16L1 and NOD2 interact in an autophagy-dependent antibacterial pathway implicated in crohn's disease pathogenesis. Gastroenterology 2010; 139:1630-1641.
13. Platinga TS, Crisan TO, Oosting M, et al. crohn's disease-Associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2. Gut 2011; 60:1229-1235.
14. Plantinga TS, Joosten LA, Netea MG. ATG16L1 polymorphisms are associated with NOD2-induced hyperinflammation. Autophagy 2011; 7:1074-1075.
15. Murdoch TB, Xu W, Stempak JM, et al. Pattern recognition receptor and autophagy gene variants are associated with development of antimicrobial antibodies in crohn's disease. Inflamm Bowel Dis 2012. doi: 10.1002/ibd.22884. [Epub ahead of print]
16. Lamkanfi M, Walle LV, Kanneganti TD. Deregulated inflammasome signaling in disease. Immunol Rev 2011; 243:163-173.
17. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-820.
18. Richardson CE, Kooistra T, Kim DH. An essential role for XBP-1 in host protection against immune activation in C. elegans. Nature 2010; 463:1092-1095.
19. Broz P, Newton K, Lamkanfi M, et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med 2010; 207:1745-1755.
20. Villani AC, Lemire M, Fortin G, et al. Common variants in the NLRP3 region contribute to crohn's disease susceptibility. Nat Genet 2009; 41:71-76.
21. Nimmo ER, Stevens C, Phillips AM, et al. TLE1 modifies the effects of NOD2 in the pathogenesis of crohn's disease. Gastroenterology 2011, 141:972-981, e971-e972.
22. Schroeder BO, Wu Z, Nuding S, et al. Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1. Nature 2011; 469:419-423.
23. Ghosh S, Dai C, Brown K, et al. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Physiol Gastrointest Liver Physiol 2011; 301:G39-G49.
24. Scharl M, Mwinyi J, Fischbeck A, et al. crohn's disease-Associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.21913. [Epub ahead of print]
25. Scharl M, Wojtal KA, Becker HM, et al. Protein tyrosine phosphatase nonreceptor type 2 regulates autophagosome formation in human intestinal cells. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.21891. [Epub ahead of print]
26. Wiede F, Shields BJ, Chew SH, et al. T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 2011; 121:4758-4774.
27. Hundorfean G, Neurath MF, Mudter J. Functional relevance of T helper 17 (Th17) cells and the IL-17 cytokine family in inflammatory bowel disease. Inflamm Bowel Dis 2012; 18:180-186.
28. Lochner M, Ohnmacht C, Presley L, et al. Microbiota-induced tertiary lymphoid tissues aggravate inflammatory disease in the absence of RORgamma t and LTi cells. J Exp Med 2011; 208:125-134.
29. Sawa S, Lochner M, Satoh-Takayama N, et al. RORgammat+innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota. Nat Immunol 2011; 12:320-326.
30. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: Regulators and effectors of immunity and tissue remodeling. Nat Immunol 2011; 12:21-27.
31. Geremia A, Arancibia-Carcamo CV, Fleming MP, et al. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208:1127-1133.
32. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12:1055-1062.
33. Lin Z, Hegarty JP, Cappel JA, et al. Identification of disease-Associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease. Clin Genet 2011; 80:59-67.
34. Steck N, Mueller K, Schemann M, Haller D. Bacterial proteases in IBD and IBS. Gut 2011. [Epub ahead of print]
35. Steck N, Hoffmann M, Sava IG, et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 2011; 141:959-971.
36. Reyes A, Haynes M, Hanson N, et al. Viruses in the faecal microbiota of monozygotic twins and their mothers. Nature 2010; 466:334-338.
37. Kim YG, Park JH, Reimer T, et al. Viral infection augments Nod1/2 signaling to potentiate lethality associated with secondary bacterial infections. Cell Host Microbe 2011; 9:496-507.
38. Cadwell K, Patel KK, Maloney NS, et al. Virus-plus-susceptibility gene interaction determines crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010; 141:1135-1145.
39. Fritz T, Niederreiter L, Adolph T, et al. crohn's disease: NOD2 autophagy and ER stress converge. Gut 2011; 60:1580-1588.
40. Treton X, Pedruzzi E, Cazals-Hatem D, et al. Altered endoplasmic reticulum stress affects translation in inactive colon tissue from patients with ulcerative colitis. Gastroenterology 2011; 141:1024-1035.
41. Martinon F, Chen X, Lee AH, Glimcher LH. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 2010; 11:411-418.
42. McGovern DP,Gardet A, Torkvist L, et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 2010; 42:332-337.
43. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science 2009; 326:1694-1697.
44. Muegge BD, Kuczynski J, Knights D, et al. Diet drives convergence in gut microbiome functions across mammalian phylogeny and within humans. Science 2011; 332:970-974.
45. Faith JJ, McNulty NP, Rey FE, Gordon JI. Predicting a human gut microbiota's response to diet in gnotobiotic mice. Science 2011; 333:101-104.
46. Kau AL, Ahern PP, Griffin NW, et al. Human nutrition, the gut microbiome and the immune system. Nature 2011; 474:327-336.
47. Fuhrer A, Sprenger N, Kurakevich E, et al. Milk sialyllactose influences colitis in mice through selective intestinal bacterial colonization. J Exp Med 2010; 207:2843-2854.
48. Michail S, Durbin M, Turner D, et al. Alterations in the gut microbiome of children with severe ulcerative colitis. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.22860. [Epub ahead of print]
49. Docktor MJ, Paster BJ, Abramowicz S, et al. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2011. doi: 10.1002/ibd.21874. [Epub ahead of print]
50. Walker AW, Sanderson JD, Churcher C, et al. High-throughput clone library analysis of the mucosa-Associated microbiota reveals dysbiosis and differences between inflamed and noninflamed regions of the intestine in inflammatory bowel disease. BMC Microbiol 2011; 11:7.
51. De Hertogh G, Lemmens B, Verhasselt P, et al. Assessment of the microbiota in microdissected tissues of crohn's disease patients. Int J Inflam 2012; 2012:505674.
52. Thomazini CM, Samegima DA, Rodrigues MA, et al. High prevalence of aggregative adherent Escherichia coli strains in the mucosa-Associated microbiota of patients with inflammatory bowel diseases. Int J Med Microbiol 2011; 301:475-479.
53. Frank DN, Robertson CE, Hamm CM, et al. Disease phenotype and genotype are associated with shifts in intestinal-Associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011; 17:179-184.
54. Rausch P, Rehman A, Kunzel S, et al. Colonic mucosa-Associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype. Proc Natl Acad Sci U S A 2011; 108:19030-19035.